Novartis
hideNovartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.172 billon in 2008 . Novartis is one of the largest healthcare companies in the world and a leading giant among pharmaceutical companies. Novartis manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. Novartis owns Sandoz, a large manufacturer of generic drugs. The company formerly owned the Gerber Products Company, a major infant and baby products producer, but sold it to Nestlé on 1 September 2007.
Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
For more information about Novartis, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with novartis
Switzerland restricts use of GlaxoSmithKline swine flu vaccine
Medicine & Health / Medications
Oct 30, 2009 |
4 / 5 (1) |
0
Switzerland on Friday restricted the use of British drugs group GlaxoSmithKline's swine flu vaccine Pandemrix, excluding pregnant women, minors and people over the age of 60.
Novartis says on track to deliver US vaccine order
Medicine & Health / Medications
Oct 29, 2009 |
not rated yet |
0
(AP) -- Swiss drugmaker Novartis AG said Thursday it is on track to meet its U.S. government order for swine flu vaccine, seeking to calm fears in recent weeks that shipments and vaccination programs may be delayed.
Novartis denies problems with swine flu vaccine
Medicine & Health / Medications
Oct 26, 2009 |
not rated yet |
0
Swiss pharmaceutical group Novartis on Monday denied that it faced hurdles in gaining regulatory approval in Switzerland for one of its swine flu vaccines because of possible bacterial contamination.
EU drug agency: License 2 swine flu vaccines
Medicine & Health / Medications
Sep 25, 2009 |
not rated yet |
0
(AP) -- The European Union's drug regulator recommended Friday that two swine flu vaccines be licensed in the 27-nation bloc to ensure their availability before the start of the normal flu season.
Sanofi to deliver swine flu vaccine in October
Medicine & Health / Medications
Sep 21, 2009 |
not rated yet |
0
(AP) -- Sanofi-Aventis SA will begin delivering the first doses of its new swine flu vaccine in the United States by mid-October, the head of France's largest pharmaceutical company said Monday.
FDA approves new swine flu vaccine
Medicine & Health / Medications
Sep 15, 2009 |
not rated yet |
0
(AP) -- The Food and Drug Administration approved the new swine flu vaccine Tuesday, a long-anticipated step as the government works to get vaccinations under way next month. Health and Human Services Secretary ...
World-first swine-flu vaccine trial reveals one dose provides 'strong immune response'
Medicine & Health / Medications
Sep 03, 2009 |
not rated yet |
0
Results from the first swine-flu vaccine trials taking place in Leicester reveal a strong immune response after just one dose.
Government enlists employers' help to contain flu
Aug 19, 2009 |
not rated yet |
0
(AP) -- Government officials are calling on U.S. businesses to help manage swine flu this fall by getting vaccines to vulnerable workers and encouraging employees with symptoms to stay home.
Glaxo starts testing its swine flu vaccine
Medicine & Health / Medications
Aug 14, 2009 |
not rated yet |
1
(AP) -- Drugmaker GlaxoSmithKline says it has started testing its swine flu vaccine in humans.
Seasonal flu vaccine shipping early, demand up
Medicine & Health / Medications
Aug 06, 2009 |
1 / 5 (1) |
0
(AP) -- The swine flu pandemic is spurring makers of seasonal flu vaccines to ship them to the U.S. market well ahead of schedule, and supplies are tightening as distributors and others snap up vaccine vials.
Novartis starts testing swine flu vaccine
Medicine & Health / Medications
Aug 05, 2009 |
3 / 5 (1) |
1
(AP) -- Swiss drugmaker Novartis has begun injecting its swine flu vaccine into people in the company's first human tests, a spokesman said Wednesday. The vaccine is being tested in a yearlong trial of 6,000 ...
Extending the shelf life of antibody drugs
Jun 29, 2009 |
2 / 5 (1) |
1
A new computer model developed at MIT can help solve a problem that has plagued drug companies trying to develop promising new treatments made of antibodies: Such drugs have a relatively short shelf life because they tend ...
Novartis produces first batch of swine flu vaccine
Jun 12, 2009 |
not rated yet |
1
Swiss drugs giant Novartis has completed a first batch of swine flu vaccine for pre-clinical trials and aims to make a version available in the fall, the company said Friday.
FDA approves new drug for deadly kidney cancer
Medicine & Health / Medications
Mar 30, 2009 |
not rated yet |
0
(AP) -- A drug from Novartis has won U.S. approval as a treatment for patients with kidney cancer that has returned after treatment with older drugs.
IL-2 immunotherapy fails to benefit HIV-infected individuals already taking antiretrovirals
Medicine & Health / HIV & AIDS
Feb 10, 2009 |
2 / 5 (1) |
0
Providing a synthetic form of the immune system protein interleukin-2 (IL-2) to HIV-infected individuals already taking combination antiretroviral therapy boosts their numbers of CD4+ T cells, the key white blood cells destroyed ...
- Pages: 1
